than is routine use of IV filters. Drugs known to have high particulate loads can be filtered through a particulategrade filter incorporated in a needle. By batching multiple orders for the same drug, numerous solutions can be compounded by use of the same filter. In addition, these needle filters cost a fraction of that for in-line IV filters.
P r o b a b l y t h e m o s t r e a s o n a b l e approach to preventing particulaterelated phlebitis is that taken by the Food and Drug Administration (FDA) and U n i t e d States P h a r m a c o p e i a (USP). They have developed standards that limit the amount of particulates allowed in IV fluids. T h e papers quoted by Falchuk that show the presence of significant amounts of "starch granules, talc, silica, or glass" in IV fluids all predate the FDA and USP standards (which were finalized in the late-1970s). 6 Further, the FDA and USP are in the process of developing standards for particulates in both additives and IV administration tubing.
7
When one considers the costs of IV filters, one needs to evaluate the costs of the filters themselves as well as costs associated with their use (hidden costs). These filters impede the flow of fluid and, thus, infusion pumps, frequent changes of IV tubing, and the time-consuming irrigations of the IV line may all be required. Just the costs of IV filters alone can be staggering. A 120-bed hospital for which I consult was spending $40,000 a year on filters and charging patients over $120,000 a year. Nationwide, costs would be enormous. It is estimated that routine use of IV filters could require more than 100 million filters annually.
8 Thus, use of filters could cost hospitals $100 to $ 2 0 0 m i l l i o n a n n u a l l y a n d cost patients three times that amount.
IV filters do reduce concentrations of some d r u g s . 9 1 0 Unless all drugs are studied for the characteristic of being removed by filters, I do not believe we can dismiss this problem as insignificant. I am not sure that all physicians will be aware of the problems of filtering drugs given in low dosages; some patients may receive sub-therapeutic concentrations of drugs.
Lastly, the phlebitis rate determined in the study by Falchuk Infection control personnel should await more data before using IV filters for all patients. Hospital cost control is an important topic in the 1980s, and infection control personnel should lead the way in this area. Certainly, now is not the time to adopt new expensive procedures unless there is solid evidence t h a t benefits will approach costs; this is why the Centers for Disease Control specifically recommends against routine use of IV filters. 14 what's and and Used All Over?
Used sharps are virtually everywhere in a medical environment. Finally, there's a system for handling these sharps that maximizes protection, maximizes convenience, and minimizes space requirements, it's called Monoject SHARPS CONTAINER and it not only promises a better way, it delivers. For complete information, write Dept. A.J. 
SHARPS CONTAINER A Sherwood
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